Zara Ahmed
Riyadh, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy.
Journal: Frontiers in immunology
Published: February 26, 2026
TUBB2A and TM4SF1 Methylation Define Prognostic Subgroups in Adult-Type Diffuse Glioma.
Journal: Cancers
Published: December 20, 2025
Recent advances in immunotherapy for gliomas: overcoming barriers and advancing precision strategies.
Journal: Frontiers in immunology
Published: August 21, 2025
Unlocking temozolomide resistance in glioblastoma: the pivotal role of MicroRNAs and in-silico insights.
Journal: Medical oncology (Northwood, London, England)
Published: April 22, 2025
Brain organoid model systems of neurodegenerative diseases: recent progress and future prospects.
Journal: Frontiers in neuroscience
Published: April 01, 2025
Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy.
Journal: Frontiers in immunology
Published: July 04, 2023
Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy.
Journal: Frontiers in immunology
Published: April 05, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026